BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 18457324)

  • 1. Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer.
    Blanco JG; Leisenring WM; Gonzalez-Covarrubias VM; Kawashima TI; Davies SM; Relling MV; Robison LL; Sklar CA; Stovall M; Bhatia S
    Cancer; 2008 Jun; 112(12):2789-95. PubMed ID: 18457324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.
    Blanco JG; Sun CL; Landier W; Chen L; Esparza-Duran D; Leisenring W; Mays A; Friedman DL; Ginsberg JP; Hudson MM; Neglia JP; Oeffinger KC; Ritchey AK; Villaluna D; Relling MV; Bhatia S
    J Clin Oncol; 2012 May; 30(13):1415-21. PubMed ID: 22124095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional significance of a natural allelic variant of human carbonyl reductase 3 (CBR3).
    Lakhman SS; Ghosh D; Blanco JG
    Drug Metab Dispos; 2005 Feb; 33(2):254-7. PubMed ID: 15537833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin.
    Lang JK; Karthikeyan B; Quiñones-Lombraña A; Blair RH; Early AP; Levine EG; Sharma UC; Blanco JG; O'Connor T
    Cardiooncology; 2021 May; 7(1):17. PubMed ID: 33975650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation.
    Armenian SH; Ding Y; Mills G; Sun C; Venkataraman K; Wong FL; Neuhausen SL; Senitzer D; Wang S; Forman SJ; Bhatia S
    Br J Haematol; 2013 Oct; 163(2):205-13. PubMed ID: 23927520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-Dose Anthracycline and Risk of Heart Failure in a Pharmacokinetic Model of Human Myocardium Exposure: Analog Specificity and Role of Secondary Alcohol Metabolites.
    Salvatorelli E; Menna P; Chello M; Covino E; Minotti G
    J Pharmacol Exp Ther; 2018 Feb; 364(2):323-331. PubMed ID: 29222131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between changes in functional cardiac parameters following anthracycline therapy and carbonyl reductase 3 and glutathione S transferase Pi polymorphisms.
    Volkan-Salanci B; Aksoy H; Kiratli PÖ; Tülümen E; Güler N; Öksüzoglu B; Tokgözoğlu L; Erbaş B; Alikaşifoğlu M
    J Chemother; 2012 Oct; 24(5):285-91. PubMed ID: 23182048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010.
    Larsen CM; Garcia Arango M; Dasari H; Arciniegas Calle M; Adjei E; Rico Mesa J; Scott CG; Thompson CA; Cerhan JR; Haddad TC; Goetz MP; Herrmann J; Villarraga HR
    JAMA Netw Open; 2023 Feb; 6(2):e2254669. PubMed ID: 36735254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for anthracycline-associated cardiotoxicity.
    Reinbolt RE; Patel R; Pan X; Timmers CD; Pilarski R; Shapiro CL; Lustberg MB
    Support Care Cancer; 2016 May; 24(5):2173-2180. PubMed ID: 26563179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally occurring variants of human CBR3 alter anthracycline in vitro metabolism.
    Bains OS; Karkling MJ; Lubieniecka JM; Grigliatti TA; Reid RE; Riggs KW
    J Pharmacol Exp Ther; 2010 Mar; 332(3):755-63. PubMed ID: 20007405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of standard low-dose anthracycline chemotherapy on late congestive heart failure in breast cancer survivors aged between 50 and 59 at diagnosis: A nationwide study.
    Chung IY; Lee JW; Moon HG; Shin KH; Han W; Son BH; Ahn SH; Noh DY
    Breast; 2020 Oct; 53():125-129. PubMed ID: 32771950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of genetic polymorphisms NCF4 rs1883112, CBR3 rs1056892, and ABCC1 rs3743527 with the cardiotoxic effects of doxorubicin in children with acute lymphoblastic leukemia.
    Gándara-Mireles JA; Lares-Asseff I; Reyes Espinoza EA; Blanco JG; González Font AE; Córdova Hurtado LP; Castañeda VL; Fierro IV; Romero LP; Reyes HA
    Pharmacogenet Genomics; 2021 Jul; 31(5):108-115. PubMed ID: 34096893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines.
    Hertz DL; Caram MV; Kidwell KM; Thibert JN; Gersch C; Seewald NJ; Smerage J; Rubenfire M; Henry NL; Cooney KA; Leja M; Griggs JJ; Rae JM
    Pharmacogenomics; 2016 Feb; 17(3):231-40. PubMed ID: 26799497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No associations between Parkinson's disease and polymorphisms of the quinone oxidoreductase (NQO1, NQO2) genes.
    Okada S; Farin FM; Stapleton P; Viernes H; Quigley SD; Powers KM; Smith-Weller T; Franklin GM; Longstreth WT; Swanson PD; Checkoway H
    Neurosci Lett; 2005 Mar; 375(3):178-80. PubMed ID: 15694256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines.
    van Dalen EC; van der Pal HJ; van den Bos C; Kok WE; Caron HN; Kremer LC
    Eur J Cancer; 2006 Oct; 42(15):2549-53. PubMed ID: 16919450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of doxorubicin to the cardiotoxic metabolite doxorubicinol is increased in a mouse model of chronic glutathione deficiency: A potential role for carbonyl reductase 3.
    Schaupp CM; White CC; Merrill GF; Kavanagh TJ
    Chem Biol Interact; 2015 Jun; 234():154-61. PubMed ID: 25446851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whites.
    Covarrubias VG; Lakhman SS; Forrest A; Relling MV; Blanco JG
    Toxicol Lett; 2006 Jul; 164(3):249-58. PubMed ID: 16478651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-Wide Association Study Identifies
    Wang X; Singh P; Zhou L; Sharafeldin N; Landier W; Hageman L; Burridge P; Yasui Y; Sapkota Y; Blanco JG; Oeffinger KC; Hudson MM; Chow EJ; Armenian SH; Neglia JP; Ritchey AK; Hawkins DS; Ginsberg JP; Robison LL; Armstrong GT; Bhatia S
    J Clin Oncol; 2023 Mar; 41(9):1758-1769. PubMed ID: 36508697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of human aldo-keto reductases, NAD(P)H:quinone oxidoreductase, and carbonyl reductases to redox-cycle polycyclic aromatic hydrocarbon diones and 4-hydroxyequilenin-o-quinone.
    Shultz CA; Quinn AM; Park JH; Harvey RG; Bolton JL; Maser E; Penning TM
    Chem Res Toxicol; 2011 Dec; 24(12):2153-66. PubMed ID: 21910479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthracycline-induced cardiotoxicity in children with cancer: strategies for prevention and management.
    Iarussi D; Indolfi P; Casale F; Martino V; Di Tullio MT; Calabrò R
    Paediatr Drugs; 2005; 7(2):67-76. PubMed ID: 15871628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.